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Whether you call it biochemistry, molecu-
lar pharmacology, or chemical biology, one
thing we can agree on is that chemists
have long sought to advance the biological
sciences. Through development of reagents,
instruments, algorithms, and technologies,
chemistry brings to biology the ability to drill
down to molecules, bonds and atoms—the
scale of matter at which all living things
converge on common principles. But one
often hears the dogma that ‘‘you can teach
a chemist to do biology but biologists cannot
learn to do chemistry.’’
Not true. There have been developments
at the forefront of chemistry that make
chemical technologies eminently accessible
to biological researchers. Did you know, for
example, that you can perform chemical re-
actions inside cells or model organisms
and transform matter like a card-carrying
synthetic chemist? Youmight use such ‘‘bio-
orthogonal chemistries’’ to monitor de novo
DNA biosynthesis using the reagent 5-ethy-
nyl-2’-deoxyuridine (EdU), protein synthesis
with azidohomoalanine (AHA), or glycan syn-
thesis with N-azidoacetylmannosamine
(ManNAz). You can genetically outfit your
protein of interest for selective chemical re-
action with small-molecule fluorophores us-
ing HaloTag, SNAP-Tag, LAP-Tag, and
related chemical innovations. Chemists
have even made it possible for biologists to
synthesize large proteins by assembly of
peptide fragments.
These chemical innovations have been
honed for transition into the hands of biolo-
gists, sometimes via commercial kits. So
open your mind to chemistry—you can,
and sometimes should, do it.1306 Cell 163, December 3, 2015 ª2015 ElseMathematical Laws of RandomnessHao Ge
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The stochastic processes of transcription
and translation inside cells can be described
mathematically by a Chemical Master Equa-
tion (CME) model, typically simulated by the
Gillespie algorithm. Recently, a simple two-
state CME model combined with the in vitro
single-molecule experiments has revealed
the molecular basis for the transcriptional
burst under an induced condition in prokary-
oticcells (Chong,S., et al.,Cell158,314–326).
The large deviation principle, a highly so-
phisticated mathematics theory developed
only in the late last century, provides an en-
ergy-like function (called landscape function)
characterizing the non-equilibrium dynamics
of living cells. The landscape function pro-
vides a rate formula for the phenotype transi-
tion—very similar to Arrhenius equation for
describing the chemical reaction taught in
most college chemistry classes. Inspired by
many recent experiments, this general
framework has recently been applied to the
case in which the gene-state switching is
neither extremely slow nor exceedingly rapid
(Ge, H., et al., Phys. Rev. Lett. 114, 078101).
This rate formula nicely explains a ‘‘tran-
scriptional noise enhancer’’ therapy for HIV
reactivation: why a class of small molecules
that enhance the gene-expression fluctua-
tions but keep the mean transcriptional ac-
tivity unaltered can significantly reactivate
the latent cells (Dar, R.D., et al., Science
344, 1392–1396). Finally, the most probable
transition path between phenotypic states
in multi-dimensional stochastic models,
usually not possible to be accurately esti-
mated intuitively, can be numerically
obtained, illustrating the power of mathe-
matical methods in understanding random
biological processes.vier Inc.Computing Power for GenomicsJian Ma and Olgica Milenkovic
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Genomics research is undergoing a para-
digm shift thanks to the development of a
myriad of new high-throughput systems for
massive data acquisition. These data come
with the promise of unprecedented insights
into fundamental molecular and cellular
mechanisms and the potential for devel-
oping models that explain how genomes
and regulatory networks function during
development and how they differ across
species and change in disease state.
Unfortunately, the intrinsic value of such
multimodality data is usually unknown, as
the systems studied are highly complex, dy-
namic, and stochastic. Hence, the following
question emerges: what methods should
we use to evaluate the statistical sufficiency
of the data and make the most informative
and accurate inference and prediction? To
address this question, computational scien-
tists have to engage with biologists in a
dialogue, which can be jump-started by a
number of exciting ideas in ‘‘evidence-
based’’ statistics, information theory, ma-
chine learning, and computer science. Small
sample detection/estimation, information
theory, and graphical models may enable
us to understand fundamental inference
limits; (causal) compressive sensing matrix
and tensor methods may enable the use of
sparsity priors; correlation clustering may
help in identifying key biological network
modules while rank aggregation and prioriti-
zation may help with both removing varying
data scales and designing biological experi-
ments; deep learning algorithms may enable
unprecedented model development.
